Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
187.32
+1.06 (0.57%)
At close: Mar 13, 2026, 4:00 PM EDT
186.83
-0.49 (-0.26%)
After-hours: Mar 13, 2026, 7:31 PM EDT
Danaher Revenue
In the year 2025, Danaher had annual revenue of $24.57B with 2.90% growth. Danaher had revenue of $6.84B in the quarter ending December 31, 2025, with 4.59% growth.
Revenue (ttm)
$24.57B
Revenue Growth
+2.90%
P/S Ratio
5.39
Revenue / Employee
$409,467
Employees
60,000
Market Cap
132.46B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.57B | 693.00M | 2.90% |
| Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
| Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
| Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
| Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
| Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
| Dec 31, 2019 | 17.91B | 862.00M | 5.06% |
| Dec 31, 2018 | 17.05B | 1.53B | 9.86% |
| Dec 31, 2017 | 15.52B | -1.36B | -8.08% |
| Dec 31, 2016 | 16.88B | 2.45B | 16.97% |
| Dec 31, 2015 | 14.43B | 1.57B | 12.18% |
| Dec 31, 2014 | 12.87B | 10.08B | 361.32% |
| Jul 31, 2014 | 2.79B | -15.49B | -84.74% |
| Dec 31, 2013 | 18.28B | 15.64B | 590.43% |
| Jul 31, 2013 | 2.65B | -15.61B | -85.50% |
| Dec 31, 2012 | 18.26B | 2.17B | 13.49% |
| Dec 31, 2011 | 16.09B | 3.54B | 28.21% |
| Dec 31, 2010 | 12.55B | 2.03B | 19.33% |
| Dec 31, 2009 | 10.52B | -2.18B | -17.17% |
| Dec 31, 2008 | 12.70B | 1.67B | 15.16% |
| Dec 31, 2007 | 11.03B | 1.56B | 16.48% |
| Dec 31, 2006 | 9.47B | 1.59B | 20.26% |
| Dec 31, 2005 | 7.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Thermo Fisher Scientific | 44.56B |
| IQVIA Holdings | 16.31B |
| Labcorp Holdings | 13.95B |
| Quest Diagnostics | 11.04B |
| Agilent Technologies | 7.07B |
| Illumina | 4.34B |
| IDEXX Laboratories | 4.30B |
| Mettler-Toledo International | 4.03B |
DHR News
- 2 days ago - Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 11 days ago - Danaher Corporation (DHR) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 17 days ago - Baron Durable Advantage Fund Q4 2025 Performance Review - Seeking Alpha
- 18 days ago - Danaher Announces Quarterly Dividend - PRNewsWire
- 18 days ago - Danaher to Present at TD Cowen Health Care Conference - PRNewsWire
- 20 days ago - Harbor Large Cap Value Fund Q4 2025 Portfolio Review - Seeking Alpha
- 26 days ago - Danaher to buy Masimo for $9.9 billion - Reuters
- 26 days ago - Masimo to be Acquired by Danaher for $180.00 Per Share - Business Wire